Adherium Limited (ADR.AX)
ASX · AUD · Healthcare · Medical Devices
A$0.067 (+0.00%) as of
Key statistics
- Market cap
- 3.68M
- Forward P/E
- 1.27
- EPS (TTM)
- -0.0000
- Dividend yield
- 0.00%
- 52-week range
- 0.0600 – 0.6720
- Beta
- 1.12
- Revenue (TTM)
- 2.1M
- Profit margin
- 0.00%
- Analyst target
- A$0.87604
- Volume
- 72.08k
About Adherium Limited
Adherium Limited, a digital health company, develops, manufactures, and supplies digital health technologies that address sub-optimal medication use and improve health outcomes in chronic diseases. The company offers Hailie Smartinhaler, a cloud-based platform which captures medication use data from Bluetooth enabled sensors which wrap around patient inhalers and provide real-time feedback to patients; Hailie Smartinhaler Sensors, a device coverage that works for Rescuer/Reliever and Preventer inhalers; Hailie solution; and Hailie Remote Patient Monitoring (RPM) Solution. It operates in New Zealand, Australia, South East Asian Countries, and North America. Adherium Limited was founded in 2001 and is based in Melbourne, Australia.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Melbourne, VIC, Australia
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.